Hepion Pharmaceuticals Overview
Hepion Pharmaceuticals Discounted Cash Flow
DCF Analysis for HEPA.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.19
Current Fair Value
$0.19
↑ 214.2% Upside
Undervalued by 214.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison